Phreesia (NYSE:PHR) Upgraded by Wall Street Zen to "Buy" Rating

Phreesia (NYSE:PHR - Get Free Report) was upgraded by Wall Street Zen from a "hold" rating to a "buy" rating in a report issued on Sunday.

Several other equities research analysts also recently weighed in on the company. DA Davidson reduced their price target on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a report on Monday, April 14th. KeyCorp cut their target price on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Citigroup restated a "buy" rating on shares of Phreesia in a research note on Wednesday, May 28th. Canaccord Genuity Group reduced their price objective on Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a research note on Thursday, May 29th. Finally, Truist Financial boosted their price target on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a report on Thursday, May 29th. Twelve research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of "Buy" and an average price target of $31.64.

Phreesia Stock Up 0.1%

Shares of PHR traded up $0.04 on Friday, reaching $25.82. The stock had a trading volume of 37,153 shares, compared to its average volume of 438,091. The firm has a market capitalization of $1.54 billion, a price-to-earnings ratio of -17.44 and a beta of 0.74. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. Phreesia has a 12-month low of $17.07 and a 12-month high of $30.53. The company has a 50-day simple moving average of $24.73 and a 200-day simple moving average of $25.36.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.06. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The firm had revenue of $115.94 million for the quarter, compared to analysts' expectations of $115.00 million. During the same quarter last year, the business posted ($0.05) earnings per share. The company's revenue for the quarter was up 14.5% compared to the same quarter last year. Sell-side analysts predict that Phreesia will post -1.1 EPS for the current year.

Insider Transactions at Phreesia

In other news, insider Yvonne Hui sold 1,878 shares of Phreesia stock in a transaction dated Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total transaction of $44,790.30. Following the completion of the sale, the insider now directly owns 28,449 shares in the company, valued at $678,508.65. The trade was a 6.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP David Linetsky sold 4,499 shares of Phreesia stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $23.73, for a total transaction of $106,761.27. Following the completion of the sale, the senior vice president now directly owns 217,239 shares of the company's stock, valued at $5,155,081.47. The trade was a 2.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 42,474 shares of company stock worth $1,023,208. Insiders own 5.50% of the company's stock.

Institutional Trading of Phreesia

Several institutional investors have recently made changes to their positions in the stock. Johnson Financial Group Inc. boosted its position in Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after buying an additional 896 shares during the last quarter. R Squared Ltd acquired a new position in Phreesia during the 4th quarter worth $30,000. BankPlus Trust Department bought a new stake in shares of Phreesia in the 4th quarter valued at approximately $34,000. Quarry LP raised its holdings in shares of Phreesia by 210.9% during the fourth quarter. Quarry LP now owns 2,835 shares of the company's stock worth $71,000 after purchasing an additional 1,923 shares during the period. Finally, KBC Group NV bought a new position in Phreesia in the first quarter worth about $74,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.